Growth Metrics

Bio-Techne (TECH) Non-Current Debt (2016 - 2026)

Bio-Techne has reported Non-Current Debt over the past 12 years, most recently at $260.0 million for Q4 2025.

  • For Q4 2025, Non-Current Debt fell 13.33% year-over-year to $260.0 million; the TTM value through Dec 2025 reached $260.0 million, down 13.33%, while the annual FY2025 figure was $346.0 million, 8.46% up from the prior year.
  • Non-Current Debt for Q4 2025 was $260.0 million at Bio-Techne, down from $300.0 million in the prior quarter.
  • Over five years, Non-Current Debt peaked at $447.0 million in Q4 2023 and troughed at $200.0 million in Q4 2022.
  • A 5-year average of $309.7 million and a median of $300.0 million in 2024 define the central range for Non-Current Debt.
  • Biggest five-year swings in Non-Current Debt: tumbled 50.18% in 2021 and later surged 123.5% in 2023.
  • Year by year, Non-Current Debt stood at $269.6 million in 2021, then dropped by 25.82% to $200.0 million in 2022, then skyrocketed by 123.5% to $447.0 million in 2023, then plummeted by 32.89% to $300.0 million in 2024, then decreased by 13.33% to $260.0 million in 2025.
  • Business Quant data shows Non-Current Debt for TECH at $260.0 million in Q4 2025, $300.0 million in Q3 2025, and $346.0 million in Q2 2025.